We are live on ! Find out more
ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

63 hedge funds and large institutions have $96.3M invested in Oncternal Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

312% more call options, than puts

Call options by funds: $7.42M | Put options by funds: $1.8M

Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
–
Reduced
–
Closed
–
Calls
$7.42M
Puts
$1.8M
Net Calls
+$5.62M
Net Calls Change
+$5.62M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$26.5M +$22.1M +2,871 New
PC
2
PointState Capital
New York
$9.9M +$8.25M +1,071 New
BIT
3
BlackRock Institutional Trust
California
$9.09M +$7.58M +984 New
BFA
4
BlackRock Fund Advisors
California
$8.16M +$6.81M +884 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$6.1M +$5.09M +660 New
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$3.91M +$3.26M +423 New
State Street
7
State Street
Massachusetts
$3.35M +$2.79M +362 New
VM
8
VHCP Management
New York
$3.3M +$2.75M +357 New
CII
9
CR Intrinsic Investors
Connecticut
$3.18M +$2.65M +344 New
VAM
10
Visium Asset Management
New York
$3.1M +$2.59M +336 New
Northern Trust
11
Northern Trust
Illinois
$2.75M +$2.29M +297 New
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$2.29M +$1.91M +248 New
JG
13
Jefferies Group
New York
$1.12M +$932K +121 New
WMSA
14
Weiss Multi-Strategy Advisers
New York
$1.12M +$932K +121 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$808K +$678K +88 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$763K +$640K +83 New
TCIM
17
TIAA CREF Investment Management
New York
$739K +$616K +80 New
AllianceBernstein
18
AllianceBernstein
Tennessee
$711K +$593K +77 New
Morgan Stanley
19
Morgan Stanley
New York
$552K +$462K +60 New
Barclays
20
Barclays
United Kingdom
$496K +$416K +54 New
Charles Schwab
21
Charles Schwab
California
$479K +$401K +52 New
BIM
22
BlackRock Investment Management
Delaware
$467K +$393K +51 New
Deutsche Bank
23
Deutsche Bank
Germany
$461K +$385K +50 New
FHC
24
First Horizon Corporation
Tennessee
$452K +$378K +49 New
Bank of America
25
Bank of America
North Carolina
$423K +$354K +46 New
1
2 3

ONCT Hedge Fund Activity: Q2 2013 in Review

63 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q2 2013, worth a combined $96.3M.

Buyers outnumbered sellers: 63 funds opened new ONCT positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $96.3M of Oncternal Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 63 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.